Skip to main content
. Author manuscript; available in PMC: 2015 Apr 30.
Published in final edited form as: Pediatr Blood Cancer. 2014 Jan 31;61(5):875–878. doi: 10.1002/pbc.24887

TABLE III.

Treatments and Outcomes for Children With Respiratory Syncytial Virus (RSV) or Seasonal Influenza and Sickle Cell Disease (SCD), Johns Hopkins Hospital 1993–2011

Variable RSV n = 64 Influenza
n = 91
P-Value
Acute chest syndrome 26% (15/58) 15% (13/84) 0.13
Hospital admission 100% 89% 0.006
Intensive care 5% 3% 0.69
Ventilatory support 5% 0% 0.07
Acute transfusion PRBC* 13% 15% 0.65
Therapy with antiviral agents 5% 40% <0.0001
Therapy with antibacterial agents 100% 97% 0.27
Therapy with bronchodilators 50% 40% 0.25
Length of stay (days)** 2 (1–3) 2 (1–3) 0.15
Hospital charges ($)** 4,599 (3,352, 6,424) 4,603 (3,117, 6,695) 0.54
*

Indicates packed red blood cells.

**

Indicates median (interquartile range).